Exogene's low-cost approach to fermentation

Exogene Corp. hopes to halve the manufacturing costs of therapeutics produced through fermentation, by coupling agroprocessing technology with its pharmacologically active molecules.

Privately held Exogene uses genetic methods to improve production strains of the aerobic microbes used to

Read the full 370 word article

How to gain access

Continue reading with a
two-week free trial.